TrialJCO precision oncology2024

TARGET: A Randomized, Noninferiority Trial of a Pretest, Patient-Driven Genetic Education Webtool Versus Genetic Counseling for Prostate Cancer Germline Testing.

Stacy Loeb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.